These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26937257)

  • 21. Evaluation of DNA methylation levels of
    Grossi I; Assoni C; Lorini L; Smussi D; Gurizzan C; Grisanti S; Paderno A; Mattavelli D; Piazza C; Pelisenco IA; De Petro G; Salvi A; Bossi P
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38299234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma.
    Fietz S; Diekmann E; de Vos L; Zarbl R; Hunecke A; Glosch AK; Färber M; Sirokay J; Hoffmann F; Fröhlich A; Franzen A; Strieth S; Landsberg J; Dietrich D
    Clin Chem; 2024 Mar; 70(3):516-527. PubMed ID: 38300881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SHOX2 DNA methylation is a tumour marker in pleural effusions.
    Ilse P; Biesterfeld S; Pomjanski N; Fink C; Schramm M
    Cancer Genomics Proteomics; 2013; 10(5):217-23. PubMed ID: 24136974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of SHOX2 and RASSF1A methylation assay in supernatants and matched cell pellets for the diagnosis of malignant pleural effusion.
    Zhang N; Li Y; Zhang H; Dong Y; Zhang C; Du W; Long C; Xing X; Li K; Liu Z; Chen X; Zhang L; Xu F; Fu Y; Tan J; She B; Che N
    Clin Chim Acta; 2024 Jan; 553():117699. PubMed ID: 38072300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Combination of SHOX2 and RASSF1A DNA Methylation Had a Diagnostic Value in Pulmonary Nodules and Early Lung Cancer.
    Xie B; Dong W; He F; Peng F; Zhang H; Wang W
    Oncology; 2024; 102(9):759-774. PubMed ID: 38262380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical significance of vascular endothelial growth factor in malignant ascites.
    Zhan N; Dong WG; Wang J
    Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.
    Dietrich D; Kneip C; Raji O; Liloglou T; Seegebarth A; Schlegel T; Flemming N; Rausch S; Distler J; Fleischhacker M; Schmidt B; Giles T; Walshaw M; Warburton C; Liebenberg V; Field JK
    Int J Oncol; 2012 Mar; 40(3):825-32. PubMed ID: 22108652
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Holmes EE; Goltz D; Sailer V; Jung M; Meller S; Uhl B; Dietrich J; Röhler M; Ellinger J; Kristiansen G; Dietrich D
    Clin Epigenetics; 2016; 8():104. PubMed ID: 27708722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic Efficacy of SHOX2 Gene Hypermethylation for Lung Cancer: A Meta-Analysis].
    Liu Q; Wang S; Pei G; Yang Y; Huang Y
    Zhongguo Fei Ai Za Zhi; 2021 Jul; 24(7):490-496. PubMed ID: 34275516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel DNA methylation panel accurately detects colorectal cancer independently of molecular pathway.
    Freitas M; Ferreira F; Carvalho S; Silva F; Lopes P; Antunes L; Salta S; Diniz F; Santos LL; Videira JF; Henrique R; Jerónimo C
    J Transl Med; 2018 Feb; 16(1):45. PubMed ID: 29486770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Semi-Nested Real-Time PCR Assay Leveraging Extendable Blocking Probes for Improved
    Phuong NA; Dao TT; Pham PB; Nguyen UD; Nguyen BV; Ho TH
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocyte subsets determination and DNA ploidy analysis in the differential diagnosis between benign and malignant ascites.
    Zhang W; Tong Q; Wang X; Wang Q; Li S
    Cancer Invest; 2009 Jan; 27(1):67-9. PubMed ID: 19160105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients.
    Matsui S; Kagara N; Mishima C; Naoi Y; Shimoda M; Shimomura A; Shimazu K; Kim SJ; Noguchi S
    Oncol Rep; 2016 Oct; 36(4):2225-35. PubMed ID: 27499429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Dynamics of Quantitative
    Krausewitz P; Kluemper N; Richter AP; Büttner T; Kristiansen G; Ritter M; Ellinger J
    Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Internal Control for Evaluating Bisulfite Conversion in the Analysis of Short Stature Homeobox 2 Methylation in Lung Cancer.
    Lan VTT; Trang VL; Ngan NT; Son HV; Toan NL
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2435-2443. PubMed ID: 31450918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascites metabolism measurement enhanced the diagnostic value and accuracy of prognostic evaluation in 18F-FDG PET/CT studies in malignant ascites patients.
    Li XJ; Li FQ; Han JK; Zhao ZH; Song ZG; Dai XZ
    Nucl Med Commun; 2013 Jun; 34(6):544-50. PubMed ID: 23511926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SHOX2 DNA methylation is a biomarker for the diagnosis of lung cancer based on bronchial aspirates.
    Schmidt B; Liebenberg V; Dietrich D; Schlegel T; Kneip C; Seegebarth A; Flemming N; Seemann S; Distler J; Lewin J; Tetzner R; Weickmann S; Wille U; Liloglou T; Raji O; Walshaw M; Fleischhacker M; Witt C; Field JK
    BMC Cancer; 2010 Nov; 10():600. PubMed ID: 21047392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EUS-guided paracentesis for the diagnosis of malignant ascites.
    Kaushik N; Khalid A; Brody D; McGrath K
    Gastrointest Endosc; 2006 Dec; 64(6):908-13. PubMed ID: 17140897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Septin 9 promoter region methylation in free circulating DNA-potential role in noninvasive diagnosis of lung cancer: preliminary report.
    Powrózek T; Krawczyk P; Kucharczyk T; Milanowski J
    Med Oncol; 2014 Apr; 31(4):917. PubMed ID: 24633736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.
    Trapé J; Gurt G; Franquesa J; Montesinos J; Arnau A; Sala M; Sant F; Casado E; Ordeig JM; Bergos C; Vida F; Sort P; Isava Á; González M; Molina R
    Anticancer Res; 2015 Oct; 35(10):5655-60. PubMed ID: 26408739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.